BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32789507)

  • 1. An approach for normalization and quality control for NanoString RNA expression data.
    Bhattacharya A; Hamilton AM; Furberg H; Pietzak E; Purdue MP; Troester MA; Hoadley KA; Love MI
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32789507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression Concordance of 325 Novel RNA Biomarkers between Data Generated by NanoString nCounter and Affymetrix GeneChip.
    Delmonico L; Attiya S; Chen JW; Obenauer JC; Goodwin EC; Fournier MV
    Dis Markers; 2019; 2019():1940347. PubMed ID: 31217830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
    Nielsen T; Wallden B; Schaper C; Ferree S; Liu S; Gao D; Barry G; Dowidar N; Maysuria M; Storhoff J
    BMC Cancer; 2014 Mar; 14():177. PubMed ID: 24625003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues.
    Tyekucheva S; Martin NE; Stack EC; Wei W; Vathipadiekal V; Waldron L; Fiorentino M; Lis RT; Stampfer MJ; Loda M; Parmigiani G; Mucci LA; Birrer M
    J Mol Diagn; 2015 Jul; 17(4):374-81. PubMed ID: 25937617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data.
    Wang H; Horbinski C; Wu H; Liu Y; Sheng S; Liu J; Weiss H; Stromberg AJ; Wang C
    Nucleic Acids Res; 2016 Nov; 44(20):e151. PubMed ID: 27471031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
    Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
    BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NanoString nCounter Technology: High-Throughput RNA Validation.
    Goytain A; Ng T
    Methods Mol Biol; 2020; 2079():125-139. PubMed ID: 31728967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues.
    Zheng CM; Piao XM; Byun YJ; Song SJ; Kim SK; Moon SK; Choi YH; Kang HW; Kim WT; Kim YJ; Lee SC; Kim WJ; Yun SJ
    Cancer Genet; 2022 Nov; 268-269():137-143. PubMed ID: 36368127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples.
    Mahoney DW; Therneau TM; Anderson SK; Jen J; Kocher JP; Reinholz MM; Perez EA; Eckel-Passow JE
    BMC Res Notes; 2013 Jan; 6():33. PubMed ID: 23360712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RCRdiff: A fully integrated Bayesian method for differential expression analysis using raw NanoString nCounter data.
    Xu C; Wang X; Lim J; Xiao G; Xie Y
    Stat Med; 2022 Feb; 41(4):665-680. PubMed ID: 34773277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new normalization for Nanostring nCounter gene expression data.
    Molania R; Gagnon-Bartsch JA; Dobrovic A; Speed TP
    Nucleic Acids Res; 2019 Jul; 47(12):6073-6083. PubMed ID: 31114909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
    Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
    Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
    Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
    Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples.
    Veldman-Jones MH; Brant R; Rooney C; Geh C; Emery H; Harbron CG; Wappett M; Sharpe A; Dymond M; Barrett JC; Harrington EA; Marshall G
    Cancer Res; 2015 Jul; 75(13):2587-93. PubMed ID: 26069246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing.
    Talla SB; Rempel E; Endris V; Jenzer M; Allgäuer M; Schwab C; Kazdal D; Stögbauer F; Volckmar AL; Kocsmar I; Neumann O; Schirmacher P; Zschäbitz S; Duensing S; Budczies J; Stenzinger A; Kirchner M
    Genes Chromosomes Cancer; 2020 Jul; 59(7):406-416. PubMed ID: 32212351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
    Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
    BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay System.
    Malkov VA; Serikawa KA; Balantac N; Watters J; Geiss G; Mashadi-Hossein A; Fare T
    BMC Res Notes; 2009 May; 2():80. PubMed ID: 19426535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denaturing fixatives are compatible with the NanoString nCounter
    Rouzier R; Roulot A; Jeiranian AH; Ram N; Guinebretiere JM; Salomon AV; Gentien D
    N Biotechnol; 2017 May; 36():37-41. PubMed ID: 28069519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
    Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
    Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RCRnorm: An integrated system of random-coefficient hierarchical regression models for normalizing NanoString nCounter data.
    Jia G; Wang X; Li Q; Lu W; Tang X; Wistuba I; Xie Y
    Ann Appl Stat; 2019 Sep; 13(3):1617-1647. PubMed ID: 33564347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.